SCHEMBL23355355

SCHEMBL23355355

COc1cc2nc(-c3ccc(Oc4nc(-c5nnc(C6CC6)o5)cs4)cc3F)nc(N)c2cc1N

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23368171 0.80 EGFR (0.45) LRRK2
SCHEMBL24926748 0.79 BACE1 (0.36) LRRK2
SCHEMBL23355413 0.77 LRRK2 (0.40) LRRK2
SCHEMBL23355338 0.72 KDM4E (0.38)
SCHEMBL23355478 0.72 MAPT (0.34)
SCHEMBL23355389 0.70 KDM4E (0.36)
SCHEMBL23355470 0.70 KDM4E (0.36)
SCHEMBL23355350 0.69 MAPK14 (0.35)
SCHEMBL21612850 0.68 MAPT (0.33)
SCHEMBL23355422 0.68 ADORA1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3822263-A1 BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2021-05-19 EP disclosed